HELICOBACTER PYLORI CAGA/VACAS1-M1 STRAIN IS ASSOCIATED WITH HIGH RISK OF FIBROSIS IN METABOLIC-DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Barreyro, Fernando [1 ]
Maiorana, Facundo [1 ]
Neschuk, Magali [1 ]
Caronia, Maria Viriginia [1 ]
Elizondo, Karina [2 ]
Schneider, Adolfo [2 ]
Veron, Georgina [2 ]
Zapata, Pedro Dario [1 ]
机构：
[1] Natl Univ Misiones, Misiones, Argentina
[2] Barcelo Univ Inst Hlth Sci, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1200
引用
收藏
页码：S914 / S915
页数：2
相关论文
共 50 条
  • [21] Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
    Chen, Hongze
    Nisar, Muhammad Azhar
    Mulla, Joud
    Li, Xinjian
    Cao, Kevin
    Lu, Shaolei
    Nagaoka, Katsuya
    Wu, Shang
    Ting, Peng-Sheng
    Tseng, Tung-Sung
    Lin, Hui-Yi
    Yin, Xiao-Ming
    Feng, Wenke
    Wu, Zhijin
    Cheng, Zhixiang
    Mueller, William
    Bay, Amalia
    Schechner, Layla
    Bai, Xuewei
    Huang, Chiung-Kuei
    EMBO MOLECULAR MEDICINE, 2025,
  • [22] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [23] Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study
    Chen, Xingcen
    Peng, Ruyi
    Peng, Dongzi
    Liu, Deliang
    Li, Rong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [24] Association between Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatic Cancer: Current Concepts and Future Challenges
    Bader, Husam
    Yamin, Saif
    Alshahwan, Hamzeh
    Farraj, Husam
    Maghnam, Joud
    Omar, Yazan Abu
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [25] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192
  • [26] Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Pei, Yiying
    Goh, George Boon-Bee
    GUT AND LIVER, 2025, 19 (01) : 8 - 18
  • [27] GASTROINTESTINAL MALIGNANCY RISK IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Nwankwo, Chizoba N.
    Eun, Yong
    Nwankwo, Obinna T.
    Osman, Mohamed K.
    Culpepper-Morgan, Joan A.
    GASTROENTEROLOGY, 2024, 166 (05) : S1474 - S1474
  • [28] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [29] DIABETES RISK INDEX IN INDIVIDUALS WITH PCOS IS ASSOCIATED METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD), CLINICALLY SIGNIFICANT FIBROSIS AND ADVANCED FIBROSIS
    Samala, Niharika
    Murthy, Sreemala
    Naidu, Suneetha
    Vilar-Gomez, Eduardo
    Chalasani, Naga
    HEPATOLOGY, 2024, 80 : S651 - S651
  • [30] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
12345